Residual Breast Tissue after Mastectomy: How Often and Where Is It Located?
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Residual breast tissue after a mastectomy can lead to a (second) primary breast cancer. The development of breast cancer after prophylactic mastectomy and the finding of normal breast tissue around a local recurrence support this assumption. The aim of the present study was to investigate the prevalence and localization of residual breast tissue after a mastectomy.
A series of 206 women who underwent a mastectomy between January 2008 and August 2009 in 11 hospitals were enrolled onto this study after written informed consent was obtained. From each mastectomy specimen, a total of 36 samples were obtained from the superficial dissection plane at predetermined locations. The biopsy samples were analyzed for the presence of benign breast tissue in the inked superficial area. Differences in percentage of positive samples were analyzed by generalized estimating equations to account for their interdependence.
A total of 7,374 biopsy samples from 206 breast specimens of 206 patients were included in the analysis. In 76.2 % of the specimens (n = 157), one or more positive biopsy samples were found. The positive findings were found diffusely across the superficial dissection surface of the specimen with a significant predilection for the lower outer quadrant and the middle circle of the superficial dissection plane.
After a mastectomy, there is a high probability of residual breast tissue. This tissue is predominantly located in the middle circle of the superficial dissection plane and in the lower outer quadrant. Surgeons should be aware of these locations so they may remove as much of the benign breast tissue as possible.
- Oncoline: cancer clinical practice guidelines. http://www.oncoline.nl. Version 2.0. Consensus based 13 Feb 2012.
- Willemsen HW, Kaas R, Peterse JH, Rutgers EJ. Breast carcinoma in residual breast tissue after prophylactic bilateral subcutaneous mastectomy. Eur J Surg Oncol. 1998;24:331–2. CrossRef
- Goodnight JE Jr, Quagliana JM, Morton DL. Failure of subcutaneous mastectomy to prevent the development of breast cancer. J Surg Oncol. 1984;26:190–201. CrossRef
- Eldar S, Meguid MM. Beatty JD. Cancer of the breast after prophylactic subcutaneous mastectomy. Am J Surg. 1984;148:692–3. CrossRef
- Pennisi VR, Capozzi A. Subcutaneous mastectomy data: a final statistical analysis of 1500 patients. Aesthetic Plast Surg. 1989;13:15–21. CrossRef
- Ziegler LD, Kroll SS. Primary breast cancer after prophylactic mastectomy. Am J Clin Oncol. 1991;14:451–4.
- Lostumbo L, Carbine N, Wallace l. Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev. 2010;(11):CD002748.
- Hartmann LC, Schaid DJ, Woods JE, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med. 1999;340:77–84. CrossRef
- Meijers-Heijboer H, van Geel B, van Putten WL, et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med. 2001;345:159–64. CrossRef
- Rebbeck TR, Friebel T, Lynch HT, et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol. 2004;22:1055–62. CrossRef
- Heemskerk-Gerritsen BA, Brekelmans CT, Menke-Pluymers MB, et al. Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experience at the Rotterdam Family Cancer Clinic. Ann Surg Oncol. 2007;14:3335–44. CrossRef
- Sacchini V, Pinotti JA, Barros AC, et al. Nipple-sparing mastectomy for breast cancer and risk reduction: oncologic or technical problem? J Am Coll Surg. 2006;203:704–14. CrossRef
- Cao D, Tsangaris TN, Kouprina N, et al. The superficial margin of the skin-sparing mastectomy for breast carcinoma: factors predicting involvement and efficacy of additional margin sampling. Ann Surg Oncol. 2008;15:1330–40. CrossRef
- Simmons RM, Fish SK, Gayle L, et al. Local and distant recurrence rates in skin-sparing mastectomies compared with non–skin sparing mastectomies. Ann Surg Oncol. 1999;6:676–81. CrossRef
- Carlson GW, Styblo TM, Lyles RH, et al. Local recurrence after skin-sparing mastectomy: tumor biology or surgical conservatism? Ann Surg Oncol. 2003;10:108–12. CrossRef
- Kroll SS, Khoo A, Singletary SE, et al. Local recurrence risk after skin-sparing and conventional mastectomy: a 6-year follow-up. Plast Reconstr Surg. 1999;104:421–5. CrossRef
- Medina-Franco H, Vasconez LO, Fix RJ, et al. Factors associated with local recurrence after skin-sparing mastectomy and immediate breast reconstruction for invasive breast cancer. Ann Surg. 2002;235:814–9. CrossRef
- Newman LA, Kuerer HM, Hunt KK, et al. Presentation, treatment, and outcome of local recurrence after skin-sparing mastectomy and immediate breast reconstruction. Ann Surg Oncol. 1998;5:620–6. CrossRef
- Patani N, Mokbel K. Oncological and aesthetic considerations of skin-sparing mastectomy. Breast Cancer Res Treat. 2008;111:391–403. CrossRef
- Simmons RM, Adamovich TL. Skin-sparing mastectomy. Surg Clin North Am. 2003;83:885–99. CrossRef
- Singletary SE, Kroll SS. Skin-sparing mastectomy with immediate breast reconstruction. Adv Surg. 1996;30:39–52.
- Rivadeneira DE, Simmons RM, Fish SK, et al. Skin-sparing mastectomy with immediate breast reconstruction: a critical analysis of local recurrence. Cancer J. 2000;6:331–5.
- Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087–106. CrossRef
- Vaughan A, Dietz JR, Aft A, et al. Patterns of local breast cancer recurrence after skin-sparing mastectomy and immediate reconstruction. Am J Surg. 2007;194:438–43. CrossRef
- Kim JH, Tavassoli F, Haffty BG. Chest wall relapse after mastectomy for ductal carcinoma in situ: a report of 10 cases with a review of the literature. Cancer J. 2006;12:92–101.
- Hicken NF. Mastectomy. Clinical pathologic study demonstrating why most mastectomies result in incomplete removal of the mammary gland. Arch Surg. 1940;40:6–14. CrossRef
- Goldman LD, Goldwyn RM. Some anatomical considerations of subcutaneous mastectomy. Plast Reconstr Surg. 1973;51:501–5. CrossRef
- Temple WJ. Lindsay RL, Magi E, Urbanski SJ. Technical considerations for prophylactic mastectomy in patients at high risk for breast cancer. Am J Surg. 1991;161:413–5. CrossRef
- Barton FE Jr, English JM, Kingsley WB, Fietz M. Glandular excision in total glandular mastectomy and modified radical mastectomy: a comparison. Plast Reconstr Surg. 1991;88:389–92. CrossRef
- Tewari M, Kumar K, Kumar M, Shukla HS. Residual breast tissue in the skin flaps after Patey mastectomy. Indian J Med Res. 2004;119:195–7.
- Torresan RZ, dos Santos CC, Okamura H, Alvarenga M. Evaluation of residual glandular tissue after skin-sparing mastectomies. Ann Surg Oncol. 2005;12:1037–44. CrossRef
- Beer GM, Varga Z, Budi S, Seifert B, Meyer VE. Incidence of the superficial fascia and its relevance in skin-sparing mastectomy. Cancer. 2002;94:1619–25. CrossRef
- de Bock GH, van der Hage JA, Putter H, Bonnema J, Bartelink H, van de Velde CJ. Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: long-term results of European Organization for Research and Treatment of Cancer studies. Eur J Cancer. 2006;42:351–6. CrossRef
- Residual Breast Tissue after Mastectomy: How Often and Where Is It Located?
Annals of Surgical Oncology
Volume 21, Issue 4 , pp 1260-1266
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
- 2. Department of Surgery, Medical Center Leeuwarden, Leeuwarden, The Netherlands
- 3. Pathology Friesland, Leeuwarden, The Netherlands
- 4. Department of Research and Registration, Comprehensive Cancer Centre The Netherlands, Utrecht, The Netherlands
- 5. Department of Health Technology and Services Research, MIRA Institute of Technical Medicine and Biomedical Technology, University of Twente, Enschede, The Netherlands
- 6. Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands